IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus
Human cytomegalovirus (HCMV) is a ubiquitous pathogen that is potentially pathogenic in immunosuppressed individuals and pregnant females during primary infection. The HCMV envelope glycoprotein B (gB) facilitates viral entry into all cell types and induces a potent immune response. AD-2 epitope is...
Main Authors: | Siddiqui, Saima, Hackl, Sarah, Ghoddusi, Hamid, McIntosh, Megan, Gomes, Ariane, Ho, Joshua, Reeves, Matthew B., McLean, Gary R. |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020
|
Subjects: | |
Online Access: | https://repository.londonmet.ac.uk/6240/1/Immunology_2020.pdf |
Similar Items
-
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies
by: Baraniak, Ilona, et al.
Published: (2018) -
A temperature-dependent virus-binding assay reveals the presence of neutralising antibodies in human cytomegalovirus gB vaccine recipients’ sera
by: Gomes, Ariane, et al.
Published: (2023) -
Epitope-specific humoral responses to human cytomegalovirus glycoprotein-B vaccine with MF59: Anti-AD2 levels correlate with protection from viremia
by: Baraniak, Ilona, et al.
Published: (2018) -
Human cytomegalovirus vaccination: progress and perspectives of recombinant gB
by: Manghera, Avneet, et al.
Published: (2016) -
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
by: Kam, Y.W., et al.
Published: (2012)